RENB

RENB

USD

Renovaro Inc. Common Stock

$1.420+0.230 (19.328%)

Echtzeitkurs

Healthcare
Biotechnologie
Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$1.190

Hoch

$1.420

Tief

$1.420

Volumen

0.12M

Unternehmensfundamentaldaten

Marktkapitalisierung

33.8M

Branche

Biotechnologie

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

0.22M

Börse

NCM

Währung

USD

52-Wochen-Spanne

Tief $1.11Aktuell $1.420Hoch $21

Ähnliche Nachrichten

AccessWire

Lunai Bioworks, Inc. to Effect 10:1 Reverse Stock Split

Measure taken to Comply with Nasdaq Rule 5550 Regarding Minimum Bid Price LOS ANGELES, CA / ACCESS Newswire / September 24, 2025 / Lunai Bioworks, Inc. ("Lunai Bioworks" or the

Mehr anzeigen
Lunai Bioworks, Inc. to Effect 10:1 Reverse Stock Split
AccessWire

Lunai Bioworks subsidiary BioSymetrics and Brigham and Women's Hospital Awarded NIH STTR Grant to Develop AI-Powered Platform for Alcohol Use Disorder Therapeutics

BETHESDA, MD / ACCESS Newswire / September 11, 2025 / Lunai Bioworks Inc.'s wholly-owned subsidiary BioSymetrics Inc. today announced the award of a prestigious Small Business Technology Transfer

Mehr anzeigen
Lunai Bioworks subsidiary BioSymetrics and Brigham and Women's Hospital Awarded NIH STTR Grant to Develop AI-Powered Platform for Alcohol Use Disorder Therapeutics
AccessWire

Lunai Bioworks Inc. Unveils Transformer Platform to Secure Generative AI and Accelerate Drug Discovery

Proprietary safety intelligence creates dual value: faster therapeutic development and biodefense. LOS ANGELES, CALIFORNIA / ACCESS Newswire / September 9, 2025 / Lunai Bioworks Inc. , an AI-powered drug

Mehr anzeigen
Lunai Bioworks Inc. Unveils Transformer Platform to Secure Generative AI and Accelerate Drug Discovery
AccessWire

Lunai Bioworks Strengthens European Strategy Through Restructuring

Company remains committed to Europe with a streamlined, growth-focused approach. LOS ANGELES, CALIFORNIA / ACCESS Newswire / September 8, 2025 / Lunai Bioworks Inc. , an AI-powered drug discovery and

Mehr anzeigen
Lunai Bioworks Strengthens European Strategy Through Restructuring

Bleiben Sie auf dem Laufenden

Preisalarme setzen, KI-Analyse-Updates und Echtzeit-Marktnachrichten erhalten.